REBECCA FULLER: Open Payments
NPI 1275262073 · HERKIMER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 28 payments from 8 companies in 2025. Trend: 2023 $193 · 2024 $829 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $155 |
| ABBVIE INC. | 5 | $98 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| SHIELD THERAPEUTICS INC | 3 | $66 |
| PFIZER INC. | 3 | $63 |
| Lundbeck LLC | 2 | $40 |
| Amgen Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, ACCRUFER, PREVNAR 20, UBRELVY, TRELEGY ELLIPTA, FARXIGA, REXULTI, QULIPTA.
Industry payments across NY — which companies pay providers there.
